Last Updated: 02/08/2024
Malaria volunteer infection studies for Plasmodium vivax
Objectives
Using existing models this project will establish volunteer infection studies for P.vivax to accelerate drug and vaccine development.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Plasmodium vivax is the second most common cause of malaria and causes 14 million cases per year. Most are in the Asia-pacific region. Despite this, there are few drugs and no vaccines available to treat P.vivax malaria. Controlled, experimental infection of healthy volunteers has been used as a safe and successful tool to study the more common species of malaria.
External reference
Themes
Date
Jan 2024 — Dec 2028
Total Project Funding
$308,071
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 2027019
AUD 456,020
Country / Project Site(s)
Related Resources
